S 16260
Alternative Names: R-60; S-16260-2Latest Information Update: 24 Oct 2021
At a glance
- Originator Servier
- Class Antiarrhythmics
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Arrhythmias